Healthcare provider profile · identity verified

Taylor Mccarty, DO

Family Practice · FORT MYERS, FL · NPI 1477946762

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	733	236
Amlodipine Besylate	Amlodipine Besylate	528	172
Levothyroxine Sodium	Levothyroxine Sodium	409	126
Rosuvastatin Calcium	Rosuvastatin Calcium	388	137
Lisinopril	Lisinopril	385	122
Pantoprazole Sodium	Pantoprazole Sodium	365	132
Losartan Potassium	Losartan Potassium	358	120
Omeprazole	Omeprazole	278	95
Tamsulosin Hcl	Tamsulosin Hcl	224	81
Metformin Hcl	Metformin Hcl	221	68
Metoprolol Succinate	Metoprolol Succinate	211	75
Simvastatin	Simvastatin	211	63
Hydrochlorothiazide	Hydrochlorothiazide	204	68
Prednisone	Prednisone	186	147
Alprazolam	Alprazolam	170	49
Metformin Hcl Er	Metformin Hcl	168	53
Allopurinol	Allopurinol	158	44
Gabapentin	Gabapentin	158	55
Fluticasone Propionate	Fluticasone Propionate	148	63
Carvedilol	Carvedilol	144	48
Metoprolol Tartrate	Metoprolol Tartrate	141	49
Mounjaro	Tirzepatide	132	30
Diclofenac Sodium	Diclofenac Sodium	130	52
Clopidogrel	Clopidogrel Bisulfate	124	42
Ezetimibe	Ezetimibe	119	42
Zolpidem Tartrate	Zolpidem Tartrate	119	29
Trazodone Hcl	Trazodone Hcl	118	42
Escitalopram Oxalate	Escitalopram Oxalate	112	37
Albuterol Sulfate Hfa	Albuterol Sulfate	111	45
Famotidine	Famotidine	111	53
Furosemide	Furosemide	103	38
Finasteride	Finasteride	102	36
Montelukast Sodium	Montelukast Sodium	98	30
Ipratropium Bromide	Ipratropium Bromide	94	51
Potassium Chloride	Potassium Chloride	91	25
Eliquis	Apixaban	88	34
Celecoxib	Celecoxib	87	36
Glimepiride	Glimepiride	86	21
Meloxicam	Meloxicam	83	32
Sertraline Hcl	Sertraline Hcl	82	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	80	23
Atenolol	Atenolol	79	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	78	34
Glipizide Er	Glipizide	77	22
Oxybutynin Chloride Er	Oxybutynin Chloride	77	26
Ondansetron Odt	Ondansetron	75	32
Ozempic	Semaglutide	75	20
Pravastatin Sodium	Pravastatin Sodium	75	23
Lorazepam	Lorazepam	70	19
Doxycycline Hyclate	Doxycycline Hyclate	64	59
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	17
Spironolactone	Spironolactone	62	20
Duloxetine Hcl	Duloxetine Hcl	61	21
Temazepam	Temazepam	59	12
Ibuprofen	Ibuprofen	55	16
Citalopram Hbr	Citalopram Hydrobromide	53	16
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	51	35
Pregabalin	Pregabalin	51	19
Alendronate Sodium	Alendronate Sodium	50	17
Torsemide	Torsemide	47	23
Fluoxetine Hcl	Fluoxetine Hcl	45	13
Jardiance	Empagliflozin	45	16
Methylprednisolone	Methylprednisolone	45	44
Paroxetine Hcl	Paroxetine Hcl	45	12
Triamcinolone Acetonide	Triamcinolone Acetonide	45	29
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	14
Synthroid	Levothyroxine Sodium	43	12
Venlafaxine Hcl Er	Venlafaxine Hcl	43	12
Tramadol Hcl	Tramadol Hcl	42	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	suppressed
Meclizine Hcl	Meclizine Hcl	41	20
Methocarbamol	Methocarbamol	40	19
Mirtazapine	Mirtazapine	40	13
Amitriptyline Hcl	Amitriptyline Hcl	38	22
Valacyclovir	Valacyclovir Hcl	38	suppressed
Baclofen	Baclofen	37	suppressed
Bupropion Xl	Bupropion Hcl	37	17
Buspirone Hcl	Buspirone Hcl	36	17
Hydralazine Hcl	Hydralazine Hcl	36	14
Ropinirole Hcl	Ropinirole Hcl	36	11
Clonazepam	Clonazepam	34	11
Warfarin Sodium	Warfarin Sodium	34	11
Sumatriptan Succinate	Sumatriptan Succinate	33	suppressed
Azelastine Hcl	Azelastine Hcl	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	13
Xarelto	Rivaroxaban	32	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	11
Nifedipine Er	Nifedipine	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	11
Sucralfate	Sucralfate	30	14
Cefdinir	Cefdinir	29	23
Irbesartan	Irbesartan	29	suppressed
Valsartan	Valsartan	28	11
Amoxicillin	Amoxicillin	27	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Diazepam	Diazepam	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	26	suppressed
Topiramate	Topiramate	26	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Latanoprost	Latanoprost	23	suppressed
Nitroglycerin	Nitroglycerin	23	13
Ramipril	Ramipril	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	21
Insulin Lispro Kwikpen U-100	Insulin Lispro	22	suppressed
Estradiol	Estradiol	21	suppressed
Fluconazole	Fluconazole	21	17
Ketoconazole	Ketoconazole	21	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	20	suppressed
Cephalexin	Cephalexin	20	15
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Naproxen	Naproxen	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Lactulose	Lactulose	17	suppressed
Mupirocin	Mupirocin	17	12
Primidone	Primidone	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Azithromycin	Azithromycin	16	14
Chlorthalidone	Chlorthalidone	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Ibu	Ibuprofen	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Glipizide	Glipizide	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Ssd	Silver Sulfadiazine	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error